Annual Operating Expenses
$123.08 M
+$27.00 M+28.10%
December 31, 2022
Summary
- As of February 9, 2025, TCRR annual total operating expenses is $123.08 million, with the most recent change of +$27.00 million (+28.10%) on December 31, 2022.
- During the last 3 years, TCRR annual operating expenses has risen by +$71.70 million (+139.54%).
Performance
TCRR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$37.47 M
+$6.46 M+20.84%
March 31, 2023
Summary
- As of February 9, 2025, TCRR quarterly total operating expenses is $37.47 million, with the most recent change of +$6.46 million (+20.84%) on March 31, 2023.
- Over the past year, TCRR quarterly operating expenses has increased by +$8.83 million (+30.82%).
Performance
TCRR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TCRR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.1% | +30.8% |
| 3 y3 years | +139.5% | +130.9% |
| 5 y5 years | +833.9% | +810.9% |
TCRR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -21.9% | at high | -36.1% |
| 5 y | 5-year | at high | -58.3% | at high | -63.8% |
| alltime | all time | at high | -91.9% | at high | -89.2% |
TCR2 Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $37.47 M(+20.8%) |
| Dec 2022 | $123.08 M(+28.1%) | $31.00 M(-0.3%) |
| Sep 2022 | - | $31.10 M(-2.1%) |
| Jun 2022 | - | $31.77 M(+10.9%) |
| Mar 2022 | - | $28.64 M(+19.6%) |
| Dec 2021 | $96.08 M(+39.9%) | $23.96 M(-8.7%) |
| Sep 2021 | - | $26.24 M(+8.0%) |
| Jun 2021 | - | $24.29 M(+12.5%) |
| Mar 2021 | - | $21.59 M(+16.3%) |
| Dec 2020 | $68.70 M | $18.57 M(+8.0%) |
| Sep 2020 | - | $17.19 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $16.72 M(+3.0%) |
| Mar 2020 | - | $16.23 M(+19.6%) |
| Dec 2019 | $51.38 M(+94.2%) | $13.57 M(-8.9%) |
| Sep 2019 | - | $14.90 M(+22.7%) |
| Jun 2019 | - | $12.14 M(+12.7%) |
| Mar 2019 | - | $10.78 M(+27.7%) |
| Dec 2018 | $26.45 M(+100.7%) | $8.44 M(+19.1%) |
| Sep 2018 | - | $7.09 M(+4.1%) |
| Jun 2018 | - | $6.81 M(+65.5%) |
| Mar 2018 | - | $4.11 M(+1.9%) |
| Dec 2017 | $13.18 M(+32.7%) | $4.04 M |
| Dec 2016 | $9.93 M | - |
FAQ
- What is TCR2 Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual operating expenses year-on-year change?
- What is TCR2 Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly operating expenses year-on-year change?
What is TCR2 Therapeutics annual total operating expenses?
The current annual operating expenses of TCRR is $123.08 M
What is the all time high annual operating expenses for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual total operating expenses is $123.08 M
What is TCR2 Therapeutics annual operating expenses year-on-year change?
Over the past year, TCRR annual total operating expenses has changed by +$27.00 M (+28.10%)
What is TCR2 Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of TCRR is $37.47 M
What is the all time high quarterly operating expenses for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly total operating expenses is $37.47 M
What is TCR2 Therapeutics quarterly operating expenses year-on-year change?
Over the past year, TCRR quarterly total operating expenses has changed by +$8.83 M (+30.82%)